<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>DARU Journal of Pharmaceutical Sciences</JournalTitle><Volume>19</Volume><Issue>5</Issue></Journal><ArticleTitle>Development of diclofenac sodium-loaded alginate-PVP K 30 microbeads using central composite design.</ArticleTitle><FirstPage>356</FirstPage><LastPage>66</LastPage><AuthorList><Author><FirstName>Ak</FirstName><LastName>Nayak</LastName></Author><Author><FirstName>S</FirstName><LastName>Khatua</LastName></Author><Author><FirstName>Ms</FirstName><LastName>Hasnain</LastName></Author><Author><FirstName>Kk</FirstName><LastName>Sen</LastName></Author></AuthorList><History><PubDate PubStatus="received"><Year>2015</Year><Month>11</Month><Day>09</Day></PubDate></History><Abstract>Diclofenac sodium is a non-steroidal anti-inflammatory agent with a short biological half-life (1-2 hr) and requires multiple dosing. This research was carried out to develop and optimize diclofenac sodium loaded alginate-PVP K 30 microbeads to eliminate the need for multiple dosing and adverse effects.Diclofenac sodium loaded alginate-PVP K 30 microbeads were prepared by ionotropic gelation. Particle size, drug release, swelling, FTIR and SEM analyses were performed.Optimized microbeads showed particle size of 0.589±0.054 to 0.620±0.067 mm, and drug entrapment efficiency of 97.88±2.86 to 98.60±3.55%. The in vitro drug release from microbeads was sustained over 10 hrs and followed controlled-release pattern. FTIR analysis indicated the possibility of intermolecular hydrogen bonding interactions, i.e., -OH…O=C in microbeads.Microbeads for oral controlled delivery of diclofenac sodium were successfully developed by ionotropic gelation.</Abstract><web_url>https://daru.tums.ac.ir/index.php/daru/article/view/402</web_url></Article></Articles>
